Intestine Bacteria and Breast Cancer Risk
Public ClinicalTrials.gov record NCT01461070. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
BRANCH:Fecal Microbiota Among Participants in a Pre-paid Health Plan
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Background: \- Some bacteria found in the large and small intestines help keep people healthy and aid digestion. They may also affect a person s risk of developing cancer. Researchers want to study the relationship between intestinal bacteria and breast cancer risk factors. They can do this by looking at stool and urine samples from postmenopausal women. Objectives: \- To study intestinal bacteria and its relationship to urine-based markers of breast cancer risk in women. Eligibility: \- Women between 55 and 69 years of age with a recent mammogram that showed no signs of cancer. Design: * Participants will be screened with a medical history and basic health questionnaire. * At home, participants will complete questionnaires about cancer risk factors and food consumption. * Participants will also collect urine and stool samples. They will send the samples to the designated labs for study. * No treatment will be provided as part of this protocol.
Study identification
- NCT ID
- NCT01461070
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 175 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 50 Years to 69 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 9, 2011
- Primary completion
- Jun 29, 2014
- Completion
- May 21, 2020
- Last update posted
- May 26, 2020
2011 – 2020
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kaiser Permanente Colorado | Denver | Colorado | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01461070, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 26, 2020 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01461070 live on ClinicalTrials.gov.